JPRN-UMIN000022000尚未招募未知
Feasibility and efficacy of gemcitabine plus albumin-bound paclitaxel combination therapy (GEM+nabPTX therapy) in patients with borderline resectable pancreatic cancer in the neoadjvant setting. - Feasibility and efficacy of GEM+nabPTX therapy in patients with borderline resectable pancreatic cancer in the neoadjvant setting
Saitama Medical Center, Saitama Medical University0 个研究点目标入组 30 人开始时间: 2016年4月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pulmonary fibrosis or interstitial pneumonitis 2) Active double cancer 3) Active infection 4) HBs antigen positive 5) patients are using flucytosine, phenytoin, warfarin 6) pregnant females, possibly pregnant females
研究者
相似试验
招募中
1 期
Safety and Efficacy for Gemcitabine plus nab-paclitaxel with MK615 combination therapy in unresected/recurrent metastatic pancreatic cancer.: Phase I/II study (PC(UR-M) GEM/nab-PTX + MK615)pancreatic cancerJPRN-jRCTs061180074FUKUBA Nobuhiko35
招募中
1 期
Safety and Efficacy for Gemcitabine plus nab-paclitaxel with MK615 combination therapy in unresected/recurrent metastatic pancreatic cancer.: Phase I/II studyunresected/recurrent metastatic pancreatic cancerJPRN-UMIN000035158Shimane University Hospital31
已完成
不适用
Phase 2 study of the combination of gemcitabine and nedaplation for treatment of previously untreated advanced squamous cell lung cancerung squamous cell carcinomaJPRN-UMIN000004833First Department of Surgery, Hamamatsu University School of Medicine25
已完成
不适用
A combination phase I/II study of gemcitabine with carboplatin for previously untreated elderly non-small cell lung cancerpreviously untreated elderly non-small cell lung cancerJPRN-C000000072West Japan Oncology Group25
进行中（未招募）
1 期
Feasibility and efficacy of adjuvant gemcitabine chemotherapy after liver transplantation for proximal bile duct cancer - pro-ductEUCTR2010-020480-21-DEniversitätsmedizin Charite45